Details for 2009731234
Up to date per 04.04.2026
Actions
Details for 2009731234
Granted/Registered
European Patent
23.03.2011 A
12.11.2014 B1
11.04.2008
GB
0806652
C07D 487/04 20060101AFI20091030BHEP
Owner
NeRRe Therapeutics LimitedStevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road Stevenage Herts SG1 2FXGB
Representative
Authorized Recipients
Robert Dr. Börnerc/o Murgitrod & Company, Bernhard-Wicki-Straße 780636 MünchenDE
Inventor
BEATO, StefaniaGlaxoSmithKline via Alessandro Fleming 2 I-37135 VeronaIT
SARTOR, FrancoGlaxoSmithKline via Alessandro Fleming 2 I-37135 VeronaIT
STEEPLES, Ian, Philipc/o GlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NYGB
Information about Fees